{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Missense mutations (A30P and A53T) in a-synuclein cause familial forms of Parkinson's disease and dementia with Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper states that A30P mutations are linked to disease causation, implying a clear link to disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the functional effects of mutations on phospholipid binding and filament assembly of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding and filament assembly are relevant to the pathogenesis of synucleinopathies, as Lewy bodies and neurites are composed of filaments.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or mention specific controls used for the assay.",
          "judgment": "No",
          "reasoning": "The methods section lacks details on replicates and controls, making it impossible to verify the presence of basic controls."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Phospholipid binding and filament assembly assays are standard techniques in the field of protein aggregation and neurodegenerative disease research.",
          "judgment": "Yes",
          "reasoning": "These assays are widely accepted in the field as relevant to synucleinopathies.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P mutation is linked to disease, and the assay is relevant. The lack of clear details on replicates and specific controls limits the strength of evidence to supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Missense mutations (A30P and A53T) in a-synuclein cause familial forms of Parkinson's disease and dementia with Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper states that A53T mutations are linked to disease causation, implying a clear link to disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the functional effects of mutations on phospholipid binding and filament assembly of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding and filament assembly are relevant to the pathogenesis of synucleinopathies, as Lewy bodies and neurites are composed of filaments.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or mention specific controls used for the assay.",
          "judgment": "No",
          "reasoning": "The methods section lacks details on replicates and controls, making it impossible to verify the presence of basic controls."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Phospholipid binding and filament assembly assays are standard techniques in the field of protein aggregation and neurodegenerative disease research.",
          "judgment": "Yes",
          "reasoning": "These assays are widely accepted in the field as relevant to synucleinopathies.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation is linked to disease, and the assay is relevant. The lack of clear details on replicates and specific controls limits the strength of evidence to supporting."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "P",
          "position": "46"
        },
        "variant_string_id": "SNCA E46P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates the functional effects of mutations on phospholipid binding and filament assembly of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "The paper investigates the functional consequences of mutations related to the development of synucleinopathies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the functional effects of mutations on phospholipid binding and filament assembly of a-synuclein.",
          "judgment": "Yes",
          "reasoning": "Phospholipid binding and filament assembly are relevant to the pathogenesis of synucleinopathies, as Lewy bodies and neurites are composed of filaments."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper does not explicitly state the number of replicates or mention specific controls used for the assay.",
          "judgment": "No",
          "reasoning": "The methods section lacks details on replicates and controls, making it impossible to verify the presence of basic controls."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Phospholipid binding and filament assembly assays are standard techniques in the field of protein aggregation and neurodegenerative disease research.",
          "judgment": "Yes",
          "reasoning": "These assays are widely accepted in the field as relevant to synucleinopathies."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46P mutation is examined within a context relevant to synucleinopathies, and the assays are standard. The absence of specific control details constrains the strength of evidence to supporting."
    }
  ]
}